Oesophageal cancer patients who suffer loss of muscle mass (sarcopenia) during neoadjuvant therapy (chemotherapy prior to surgery) survive, on average, 32 months less than patients with no sarcopenia. This is the central ...
Feb 14, 2017
0
0
With few treatment options available to patients with advanced bladder cancer, investigators are looking for novel molecular targets. In a study published in The American Journal of Pathology, researchers report that more ...
Dec 12, 2016
0
0
About one third of cancer patients die because of cachexia - an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely with increased food intake. ...
Nov 4, 2016
0
0
Biologists at Caltech have developed a new system for visualizing connections between individual cells in fly brains. The finding may ultimately lead to "wiring diagrams" of fly and other animal brains, which would help researchers ...
Nov 2, 2016
0
48
A blood test that has shown promise in predicting how cancer will progress and what treatments will be most effective for a given patient may not be reliable for either, according to a new Penn Medicine study published this ...
Oct 27, 2016
0
1
Aspirin's reign as "the wonder drug" may have a serious challenger if new research by a team of scientists from the United States and Brazil pans out. That's because they have identified an enzyme, called "soluble guanylate ...
Jun 9, 2016
0
0
Cancer patients who receive a particular type of chemotherapy called doxorubicin run a risk of sustaining severe, lasting heart damage. But it is not possible to predict who is likely to experience this serious side effect. ...
Apr 18, 2016
0
11
UT Southwestern Medical Center cardiology researchers have identified molecular ties between the growth of cancer cells and heart cells that suggest existing cancer drugs may be able to help those with enlarged heart cells—a ...
Apr 15, 2016
0
106
Bladder cancer is the fourth most common cancer among men in the United States. While low-grade tumors have a very favorable prognosis, muscle-invasive and metastatic tumors have poorer survival rates.
Mar 17, 2016
0
0
MIPT scientists together with their colleagues from St. Petersburg and Israel have analyzed more than 500 previously published scientific articles and proposed their own approach to the choice of methods used for the treatment ...
Feb 10, 2016
0
2
